CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 251 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01479478
NCT01479478N/ACompleted
CompareCT.gov

Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.

Stanford University·interventional·Posted Nov 24, 2011·Updated Aug 20, 2018

In Brief

A clinical study evaluating Placebo and Probiotic dietary supplement for Infection and Pregnancy. Completed, enrolled 251 participants across 3 sites.

Detailed Summary

The investigators wish to determine if oral probiotic supplementation during the second half of pregnancy decreases maternal GBS recto-vaginal colonization at 35-37 weeks' gestational age, thereby decreasing need for maternal antibiotic administration at time of labor. The importance of this study is that it may offer a safer alternative to antibiotic treatment of group B Streptococcus (GBS) colonized pregnant women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfection, Pregnancy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 24, 2011
Enrollment StartNov 1, 2011
Primary CompletionJul 26, 2017
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 14.6 years ago

Interventions

Placebodrug

One placebo capsule daily.

Probiotic dietary supplementdietary

Dietary Supplement: Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC -14